Translational Medicine: Challenges and new orthopaedic vision (Mediouni-Model)
AffiliationUniversity of Chester, UK
MetadataShow full item record
AbstractBackground: In North America and three European countries Translational Medicine (TM) funding has taken center stage as the National Institutes of Health (NIH), for example, has come to recognize that delays are common place in completing clinical trials based upon benchside advancements. Recently, there are several illustrative examples whereby the translation of research had untoward outcomes requiring immediate action. Methods: Focus more on three-dimensional (3D) simulation, biomarkers, and Artificial Intelligence may allow orthopaedic surgeons to predict the ideal practices before orthopaedic surgery. Using the best medical imaging techniques may improve the accuracy and precision of tumor resections. Results: This article is directed at the young surgeon scientist and in particular orthopaedic residents and all other junior physicians in training to help them better understand TM and position themselves in career paths and hospital systems that strive for optimal TM. It serves to hasten the movement of knowledge garnered from the benchside and move it quickly to the bedside. Conclusions: Communication is ongoing in a bidirectional format. It is anticipated that more and more medical Centers and institutions will adopt TM models of healthcare delivery.
CitationMediouni, M., Madiouni, R., Gardner, M. & Vaughan, N. (2019), Translational medicine: Challenges and new orthopaedic vision (Mediouni-Model), Current Orthopaedic Practice, Wolters Kluwer, 31(2). 10.1097/BCO.0000000000000846
PublisherLippincott, Williams & Wilkins
JournalCurrent Orthopaedic Practice
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/